For most of the synthetic cannabinoids made thus far, the adverse effects typically outweigh their clinical uses says biologist João Pedro Silva from the College of Porto in Portugal, who experiments the toxicology of compound abuse, and coauthored a 2023 assessment from the positives and negatives of these drugs from theBoth individuals acquired